A cumulative autoimmune response to periplakin, envoplakin, BPAG1, and desmoplakin has been described in persons affected by paraneoplastic pemphigus that results in a dismal prognosis with a 75–90% mortality rate and a mean survival < 1 year [62]. This evidence concerns the gene PPL and paraneoplastic pemphigus.